Publicaciones en colaboración con investigadores/as de Hospital de Fuenlabrada (23)

2024

  1. Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis

    Autoimmunity Reviews

  2. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

2022

  1. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*

    British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152

  2. Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer

    Science of the Total Environment, Vol. 843

  3. Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study (PANMEKID)

    European Journal of Surgical Oncology, Vol. 48, Núm. 1, pp. 133-141

2021

  1. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

  2. Immune thrombocytopenia and COVID-19: Case report and review of literature

    Lupus, Vol. 30, Núm. 9, pp. 1515-1521

  3. Sensorimotor tongue evaluation and rehabilitation in patients with sleep-disordered breathing: a novel approach

    Journal of Oral Rehabilitation, Vol. 48, Núm. 12, pp. 1363-1372

2020

  1. Matching burden of skin diseases, demand for dermatological consultations and clinical research activity: results from three national studies

    British Journal of Dermatology

  2. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

    Autoimmunity Reviews, Vol. 19, Núm. 5

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  2. Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

    Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 55-64

  3. Multicentric study on total pancreatectomies

    Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384

2016

  1. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies

    Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399

  2. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472

2015

  1. Venous thromboembolism in patients immobilised at home

    European Respiratory Journal

2014

  1. Long-term effectiveness of glatiramer acetate in clinical practice conditions

    Journal of Clinical Neuroscience, Vol. 21, Núm. 12, pp. 2212-2218

2012

  1. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

  2. Outcome of operation in patients with adrenocortical cancer invading the inferior vena cava - A European Society of Endocrine Surgeons (ESES) survey

    Langenbeck's Archives of Surgery, Vol. 397, Núm. 2, pp. 225-231

2011

  1. Cirugía suprarrenal en España: Resultados finales de una encuesta nacional

    Cirugia Espanola, Vol. 89, Núm. 10, pp. 663-669